Immuno 2026 Day 5 Highlights: Engineered Cell Therapies, Solid Tumors, and the Future of Pediatric Immunotherapy
Fatima Cardoso Named Candidate for UICC Board of Directors 2026–2028
Merck Enters $2.13 Billion License Agreement for SciBrunch’s Investigational Oral KRAS G12D (ON) Inhibitor SPR2015
Applications are Open for the Improving Cancer Outcomes and Leadership Course - ESO
ITM and Lumara Bio Present Real-World Re-treatment Data and Dosimetry Results for ¹⁷⁷Lu-Edotreotide (ITM-11) in GEP-NETs at ASTRO 2026
CancerWorld Explores Tanzania’s Transformation in Childhood Cancer Care
10 Must-Read Posts In GI Oncology This Week
Tiffany Patrick: How The Max Foundation Transforms Access Into Patient Impact?
